Old Web
English
Sign In
Acemap
>
authorDetail
>
J. van Duzer
J. van Duzer
Novartis
Biology
Biochemistry
Whole blood
NADPH oxidase
Flow cytometry
3
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
WS06-3 Administration of ELX-02 to healthy volunteers demonstrates dose-linearity and proportionality as well as low inter-subject variability
2019
Journal of Cystic Fibrosis
A. Leubitz
J. van Duzer
N. Sharpe
Show All
Source
Cite
Save
Citations (0)
Flow cytometric assessment of NADPH oxidase inhibitors in whole blood
1995
Inflammation Research
William O. Haston
J. van Duzer
Joseph Quintavalla
Show All
Source
Cite
Save
Citations (3)
CGS 26529: the biological profile of a novel, orally active 5-lipoxygenase inhibitor with an extended duration of action.
1995
Inflammation Research
Earl F. Kimble
Timothy J. Kowalski
P. Peters
Warren Lee
Julie Koehler
A. Raychaudhuri
Herbert Chertock
V. Blancuzzi
J. van Duzer
Show All
Source
Cite
Save
Citations (1)
1